Improving brain imaging for early detection of cancer spread
Two-way Magnetic Resonance Tuning Nanoprobe Enhanced Subtraction Imaging for Precision Diagnosis of Brain Metastasis
This study is working on a new way to spot tiny brain tumors from other cancers using special imaging techniques, which could help doctors find and treat these tumors earlier for patients who need it.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California at Davis NIH-funded |
| Lab location | 1 site (Davis, United States) |
| Project ID | NIH-10987003 on NIH RePORTER |
What this research studies
This research focuses on enhancing the ability to detect small brain metastases from systemic cancers using advanced imaging techniques. By developing a novel molecular nanoprobe that improves the contrast between tumors and normal brain tissue, the study aims to visualize early-stage brain metastases non-invasively. The approach combines a new two-way magnetic resonance tuning method with advanced computational techniques to achieve high sensitivity and spatial resolution in imaging. This could lead to earlier diagnosis and treatment options for patients with brain metastases.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with systemic cancers who are at risk of developing brain metastases.
Not a fit: Patients with primary brain tumors or those without a history of systemic cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve early detection of brain metastases, leading to better treatment outcomes and reduced mortality rates.
How similar studies have performed: Previous research has shown promise in using advanced imaging techniques for cancer detection, suggesting that this approach could be effective.
Where this research is happening
Davis, United States
- University of California at Davis — Davis, United States (Active)
Researchers
- Principal investigator: Li, Yuanpei — University of California at Davis
- Study coordinator: Li, Yuanpei
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.